Literature DB >> 20512108

Intranasal/intravenous sedation for the dental care of adults with severe disabilities: a multicentre prospective audit.

N J Ransford1, M C G Manley, D A Lewis, S A Thompson, L J Wray, C A Boyle, L P Longman.   

Abstract

OBJECTIVE: This study was designed to provide an evaluation of the combined intranasal/intravenous midazolam sedation technique. It involved adults with severe disabilities which prevented them from being able to co-operate with dental treatment and intravenous cannulation for sedation.
METHOD: Following a previous retrospective audit, additional treatment centres were enrolled and a standardised form used to collect prospective data about the effectiveness of the technique in facilitating cannulation, dental examination and treatment. Data was also collected on safety and patient acceptability.
RESULTS: In a total of 316 sedation episodes in primary and secondary care settings, cannulation was achieved in 96.2% (304). Dental examination and treatment was able to be carried out without major interference from the patient in 78.8% (241) episodes. Adverse sedation events occurred in 6.0% (19), the most frequent being desaturation which was easily managed. There were no incidents with serious sequelae. Favourable acceptability ratings were given by carers regarding advantages of ease of administration and speed of onset of the intranasal dose, plus reduction in the stress associated with cannulation and treatment.
CONCLUSIONS: This study provides further evidence to support the effectiveness, safety and acceptability of this technique. The authors suggest this provides sufficient basis to justify its use by suitably trained dental practitioners in primary care as part of the spectrum of anxiety and behaviour management for this group.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20512108     DOI: 10.1038/sj.bdj.2010.501

Source DB:  PubMed          Journal:  Br Dent J        ISSN: 0007-0610            Impact factor:   1.626


  5 in total

1.  Risk factors with intravenous sedation for patients with disabilities.

Authors:  Fumihiro Yoshikawa; Yoh Tamaki; Hisa Okumura; Zenzo Miwa; Masaaki Ishikawa; Kazuhiro Shimoyama; Zenkou Nakamura; Hitomi Kunimori; Shigeharu Jinno; Hikaru Kohase; Haruhisa Fukayama
Journal:  Anesth Prog       Date:  2013

Review 2.  Specialist management of routine dental procedures in adults with refractory epilepsy.

Authors:  N Ransford; I Soryal; D McCorry; J W Sander; F Duncan; N Huggins
Journal:  Br Dent J       Date:  2014-04       Impact factor: 1.626

3.  Intranasal midazolam for the sedation of geriatric patients with care-resistant behaviour during essential dental treatment: An observational study.

Authors:  Clemens R M Barends; Anthony R Absalom; Anita Visser
Journal:  Gerodontology       Date:  2021-03-21       Impact factor: 2.750

4.  The Efficacy of Two Intravenous Sedative Drugs in Management of Uncooperative Children for Dental Treatments.

Authors:  Nasser Kaviani; Sanaz Ashrafi; Seyed Ebrahim Jabbarifar; Elham Ghaffari
Journal:  J Dent (Shiraz)       Date:  2015-03

5.  Conscious sedation procedures using intravenous midazolam for dental care in patients with different cognitive profiles: a prospective study of effectiveness and safety.

Authors:  Valérie Collado; Denise Faulks; Emmanuel Nicolas; Martine Hennequin
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.